Release date: 2 February 2026
Promoter – Financial Intermediary
EDAP TMS SALocation
Description
The project will finance research & development (R&D) to further develop a robotic medical technology using high-intensity focused ultrasound to treat various medical conditions such as prostate cancer and endometriosis.
Objectives
The project focuses on the development of Focal One, an innovative device for prostate cancer treatment which leverages the High Intensity Focused Ultrasound technology (HIFU). The project also entails R&D, including clinical research, for specific new applications and treatments such as Endometriosis and Benign Prostate Hyperplasia (BPH).
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 36 million
Total cost (Approximate amount)
EUR 78 million
Environmental aspects
The project would not require an Environmental Impact Assessment (EIA) under Directive 2014/52/EU amending the Directive 2011/92/EC as research, development and innovation activities will be carried out in facilities already authorised for the same purpose. Full environmental details will nevertheless be verified to align with EU best practices.
Procurement
The EIB will require that all project contracts are procured in accordance with the applicable EU procurement legislation.
Status
Signed - 17/10/2025